GSK

Pfizer is spinning off its off-patent and generics business UpJohn, and combining it with generic drugmaker Mylan to create a giant off-patent group w(...)

Pfizer is expected to announce on Monday that it will combine its off-patent assets with Mylan’s $10 billion (€9 billion) generics business in a stock(...)

GlaxoSmithKline beat second quarter profit expectations with the help of strong demand for its shingles vaccine, prompting the British drugmaker to f(...)

UK pharmaceutical company GlaxoSmithKline is poised to name Jonathan Symonds, a former executive at rivals AstraZeneca and Novartis, as its next chair(...)

Markets ended the week on a cautious note, with European shares a mixed bag and the FTSE notching up its seventh day in the red. Disappointing data f(...)

While the headlines might be dominated by huge investments in the Dublin region by tech giants like Facebook, Google and Intel, the fact remains that (...)

Weak German economic data and a profit warning from Daimler hit European stock markets on Monday as investors reined in any bets on a fourth week of g(...)

Protesters against Donald Trump are expected to shut down parts of central London on Tuesday, the second day of the president’s state visit to Britain(...)

European shares recovered from early losses to end Monday higher as gains in healthcare stocks helped head off weakness in trade-sensitive sectors suc(...)

Irish shares outperformed European peers yesterday but bank stocks in Italy took a hit as concerns about a possible fine on the country exacted a hea(...)